Skip to main content
. 2015 Feb 2;10:975–999. doi: 10.2147/IJN.S68861

Figure 2.

Figure 2

Targeting of nanomedicines by the enhanced permeability and retention (EPR) effect.

Notes: Differences between normal (A) and tumor (B) vessels are depicted. Tumor vessels contain large fenestrations between the endothelial cells: this structural characteristic allows the nanoparticles (NPs) to reach the matrix and the tumor cells by the EPR effect. Conversely, normal tissue contains tightly joined endothelial cells: this prevents the diffusion of NPs outside the blood vessels.